End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.97 CNY | -1.32% |
|
-1.76% | -7.21% |
Jun. 18 | Hengrui Pharmaceuticals, Subsidiary Get Regulatory Nod to Test Two Drugs | MT |
Jun. 05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.21% | 36.79B | |
+52.93% | 803B | |
+40.55% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+17.13% | 244B | |
+1.39% | 226B | |
+6.24% | 164B | |
-4.79% | 155B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Jiangsu Hengrui Medicine Co., Ltd.(XSSC: 600276) added to FTSE All-World Index